Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
5 hedge funds and large institutions have $65.8K invested in Meihua International Medical Technologies in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0.01% (-0.01%)
44% less capital invested
Capital invested by funds: $118K → $65.8K (-$52.1K)
44% less funds holding
Funds holding: 9 → 5 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$6.02K |
| 2 |
Renaissance Technologies
New York
|
+$4.32K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.73K |
| 4 |
MG
Marex Group
London,
|
+$1.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$50.5K |
| 2 |
Two Sigma Investments
New York
|
-$9.34K |
| 3 |
Jane Street
New York
|
-$8.89K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$6.37K |
| 5 |
Morgan Stanley
New York
|
-$934 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $37.5K | +$2.73K | +74 | +9% |
|
|
2
Renaissance Technologies
New York
| $9.64K | +$4.32K | +117 | +94% |
|
|
TSS
3
Two Sigma Securities
New York
| $6.5K | +$6.02K | +163 | New |
|
|
MG
4
Marex Group
London,
| $6.49K | +$1.55K | +42 | +35% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $5.76K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$50.5K | -1,505 | Closed |
|
|
7
Two Sigma Investments
New York
| – | -$9.34K | -278 | Closed |
|
|
8
Jane Street
New York
| – | -$8.89K | -265 | Closed |
|
|
XT
9
XTX Topco
George Town,
Cayman Islands
| – | -$6.37K | -190 | Closed |
|
|
10
Morgan Stanley
New York
| – | -$934 | -28 | Closed |
|
MHUA Hedge Fund Activity: Q2 2025 in Review
5 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q2 2025, worth a combined $65.8K — down 44% from $118K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MHUA and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $6.02K. The largest seller was Citadel Advisors, exiting entirely with an estimated $50.5K sold.
- 5 institutional investors held Meihua International Medical Technologies (MHUA) as of Q2 2025, down from 9 in Q1 2025.
- Funds reported $65.8K of Meihua International Medical Technologies stock for Q2 2025, down 44% quarter-over-quarter.
- 1 fund opened new Meihua International Medical Technologies positions in Q2 2025 and 5 closed out, a net change of -4 holders.
- The largest Meihua International Medical Technologies buyer in Q2 2025 was Two Sigma Securities, an estimated $6.02K added.
- The largest Meihua International Medical Technologies seller in Q2 2025 was Citadel Advisors, an estimated $50.5K sold.
Based on aggregated 13F filings for Q2 2025.